A modified fragment of growth hormone that specifically targets fat metabolism — without affecting blood sugar, growth, or muscle. Prescribed by licensed Arizona providers.
AOD-9604 is a modified fragment (amino acids 177-191) of human growth hormone. It was specifically engineered to isolate GH's fat-burning properties without the growth or blood sugar effects.
Originally developed by Monash University in Australia, it has a strong research foundation. AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation).
Unlike full GH or GH peptides, AOD-9604 doesn't affect IGF-1 levels, making it a cleaner option for patients focused purely on fat loss.
AOD-9604 is available now at Voxy, prescribed by licensed telehealth providers in Arizona as part of a personalized fat loss protocol.
Targeted fat metabolism without the trade-offs of full growth hormone therapy.
Specifically designed to break down fat without affecting muscle, growth, or blood sugar.
Unlike GH peptides, AOD-9604 doesn't raise IGF-1, making it suitable for patients where that's a concern.
More affordable than full GH optimization protocols, making it accessible for patients focused on fat loss.
Minimal side effects reported in clinical studies; well-tolerated.
AOD-9604 works by mimicking the specific region of growth hormone responsible for fat metabolism. It stimulates lipolysis (breaking down stored fat) and inhibits lipogenesis (preventing new fat formation) — without triggering the broader effects of growth hormone like increased IGF-1, blood sugar changes, or tissue growth.
Different tools for fat loss and body composition. Here's how they compare.
Targets fat metabolism directly. No appetite suppression, no blood sugar effects. Affordable. Best for patients who want focused fat loss without systemic effects.
Powerful appetite suppression plus fat loss, but affects blood sugar, common GI side effects, expensive, and muscle loss concerns.
Broader optimization — sleep, recovery, body composition. Higher cost and affect IGF-1 levels. Best for patients who want full GH optimization beyond just fat loss.
Not sure which approach is right for you? Your provider will recommend the best option based on your goals, labs, and budget.
Book a free consultation to discuss your fat loss goals. Your provider will design a personalized AOD-9604 protocol tailored to you.
Book Free ConsultationYes. AOD-9604 is available now at Voxy, prescribed by licensed telehealth providers in Arizona. Book a free consultation to get started.
Sermorelin and tesamorelin stimulate your body's full growth hormone production — affecting sleep, recovery, body comp, and more. AOD-9604 only targets the fat metabolism pathway. It's narrower in scope but more affordable and doesn't affect IGF-1.
Different mechanisms. Ozempic (semaglutide) suppresses appetite and affects blood sugar regulation. AOD-9604 directly targets fat breakdown without appetite suppression or blood sugar effects. Some patients prefer AOD-9604 for its cleaner side effect profile. Your provider can help you compare options.
Clinical studies show AOD-9604 is well-tolerated. Some patients report mild injection site reactions or headache. It doesn't affect blood sugar, appetite, or growth hormone levels.
Yes. AOD-9604 can complement GH peptides like sermorelin for patients who want both broad optimization and enhanced fat metabolism. Your provider will design the combination.
Treatments that complement AOD-9604 or target different goals.
The effective, affordable GHRH analog. Decades of safety data for sleep, recovery, and growth hormone optimization.
Learn More →
The premium, FDA-approved growth hormone peptide. Clinically proven to reduce visceral fat and optimize metabolic health.
Learn More →
The cellular fuel your body runs on. Injectable NAD+ supports mental clarity, sustained energy, and cellular repair.
Learn More →Book your free consultation and your provider will build a personalized protocol based on your goals — not a one-size-fits-all menu.
Get Started — Free Consultation